The Effective Statistician - in association with PSI

The Effective Statistician - in association with PSI

The Effective Statistician - in association with PSI

R-Tool For Bayesian Statistics in Early Phase

Download it: MP3 | AAC | OGG | OPUS

Key points:

  • Bayesian Framework
  • PSI Conference with Audrey
  • Early-Phase Trials on binary endpoints for decision-making.
  • Commitment to open-source development and collaboration.
  • Clinical Decision Process
  • Binary Endpoints
  • Oncology Focus
  • User Experience
  • Collaboration
  • Efficiency Gain
  • Software Engineering
  • User Feedback
  • Community Involvement

As we wrap up, it's clear that better decision-making in early-phase clinical trials is not just a necessity but a transformative step for the industry. Audrey’s innovative R package, grounded in a Bayesian framework, exemplifies how advanced statistical tools can drive efficiency and accuracy.

Don't miss out on this deep dive into cutting-edge statistical software. Listen to the full episode to learn more, and be sure to share it with your colleagues who are passionate about improving clinical trial methodologies. Together, we can drive the future of effective statistics.


Comments


New comment

By submitting your comment you agree that the content of the field "Name or nickname" will be stored and shown publicly next to your comment. Using your real name is optional.

About this podcast

The podcast from statisticians for statisticians to have a bigger impact at work. This podcast is set up in association with PSI - Promoting Statistical Insight. This podcast helps you to grow your leadership skills, learn about ongoing discussions in the scientific community, build you knowledge about the health sector and be more efficient at work. This podcast helps statisticians at all levels with and without management experience. It is targeted towards the health, but lots of topics will be important for the wider data scientists community.

by Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry

Subscribe

Follow us